Aquestive Therapeutics, Inc. Common Stock AQST
$4.66
+3.67%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $9.33
- Implied Upside
- +100.3%
- Price Target Range
- $8.00 – $12.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-11-07 | Piper SandlerDavid Amsellem |
Maintains | Overweight | $5 → $8 |
| 2025-10-09 | JMP SecuritiesJason Butler |
Maintains | Market outperform | $9 → $12 |
| 2025-09-08 | OppenheimerFrancois Brisebois |
Maintains | Outperform | $7 → $8 |
| 2025-06-17 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2025-06-02 | OppenheimerAndreas Argyrides |
Assumes | Outperform | $15 → $7 |
| 2025-05-15 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2025-04-02 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2025-03-10 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2025-03-07 | Lake StreetThomas Flaten |
Maintains | Buy | $10 → $8 |
| 2024-12-20 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2024-12-17 | Cantor FitzgeraldKristen Kluska |
Initiates coverage on | Overweight | $17 |
| 2024-11-11 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2024-11-06 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2024-10-25 | Leerink PartnersRoanna Ruiz |
Maintains | Outperform | $12 → $13 |
| 2024-10-25 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $10 |
| 2024-10-08 | JMP SecuritiesJason Butler |
Reiterates | Market outperform | $9 |
| 2024-09-30 | JMP SecuritiesJason Butler |
Reiterates | Market outperform | $9 |
| 2024-09-30 | Leerink PartnersRoanna Ruiz |
Reiterates | Outperform | $10 → $12 |
| 2024-09-30 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $9 → $10 |
| 2024-08-14 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $9 |
| 2024-08-12 | JMP SecuritiesJason Butler |
Reiterates | Market outperform | $9 |
| 2024-07-26 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $9 |
| 2024-06-26 | JMP SecuritiesJason Butler |
Reiterates | Market outperform | $9 |
| 2024-06-05 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $9 |
| 2024-05-10 | Leerink PartnersRoanna Ruiz |
Initiates coverage on | Outperform | $8 |
| 2024-05-09 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $9 |
| 2024-04-30 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $9 |
| 2024-04-11 | Piper SandlerDavid Amsellem |
Initiates coverage on | Overweight | $10 |
| 2024-04-05 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $9 |
| 2024-03-28 | Raymond JamesGary Nachman |
Initiates coverage on | Outperform | $7 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.66
- Market Cap
- $584.88 million
- 52-Week Range
- $2.93 – $7.55
- Average Volume
- 3.06 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.